Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Peptide Technology Big at DSM - Happi

Peptide Technology Big at DSM

By: Happi Staff

DSM, which continues to be a leader in peptide research, is touting Syn-Star, an innovation based on existing patented peptide technology. The enzyme PLOD3 (procollagen-lysine, 2-oxogulatarate 5-dioxygenase 3) is known to be important for the stability of intermolecular collagen crosslinks. New in-vitro tests confirmed that Syn-Star stimulates PLOD3, increasing collagen stability, specifically in mature skin, by a factor of more than 4.
 
According to DSM, data from recent research revealed a positive effect of Syn-Star on sebum flow. Additionally, in an invitro assay, Syn-Star was shown to inhibit DPP4, a key enzyme involved in sebum flow.
 
At the company’s stand (921) is the Beauty Maximizer Mask with Syn-Star 4%, niacinamide PC 4% and Pentavin 1% that NYSCC Suppliers Day visitors can take home for test drive.

Keep Up With Our Content. Subscribe To Happi Newsletters